BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26179251)

  • 1. Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study.
    Chellapandian D; Shaikh F; van den Bos C; Somers GR; Astigarraga I; Jubran R; Degar B; Carret AS; Mandel K; Belletrutti M; Dix D; Visser J; Abuhadra N; Chang T; Rollins B; Whitlock J; Weitzman S; Abla O
    Pediatr Blood Cancer; 2015 Dec; 62(12):2162-6. PubMed ID: 26179251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco.
    Willis B; Ablin A; Weinberg V; Zoger S; Wara WM; Matthay KK
    J Clin Oncol; 1996 Jul; 14(7):2073-82. PubMed ID: 8683239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of outcome in children with Langerhans cell histiocytosis.
    Jubran RF; Marachelian A; Dorey F; Malogolowkin M
    Pediatr Blood Cancer; 2005 Jul; 45(1):37-42. PubMed ID: 15768381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Craniospinal Langerhans cell histiocytosis in children: 30 years' experience at a single institution.
    Davidson L; McComb JG; Bowen I; Krieger MD
    J Neurosurg Pediatr; 2008 Mar; 1(3):187-95. PubMed ID: 18352762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary musculoskeletal Langerhans cell histiocytosis in children: an analysis for a 3-decade period.
    Arkader A; Glotzbecker M; Hosalkar HS; Dormans JP
    J Pediatr Orthop; 2009 Mar; 29(2):201-7. PubMed ID: 19352248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Langerhans cell histiocytosis: retrospective analysis of 217 cases in a single center.
    Yağci B; Varan A; Cağlar M; Söylemezoğlu F; Sungur A; Orhan D; Yalçin B; Akyüz C; Kutluk T; Büyükpamukçu M
    Pediatr Hematol Oncol; 2008 Jun; 25(5):399-408. PubMed ID: 18569842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis.
    Grois N; Prayer D; Prosch H; Minkov M; Pötschger U; Gadner H
    Pediatr Blood Cancer; 2004 Jul; 43(1):59-65. PubMed ID: 15170891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy in soft-tissue lesions in histiocytosis X (Langerhans' cell histiocytosis).
    Gramatovici R; D'Angio GJ
    Med Pediatr Oncol; 1988; 16(4):259-62. PubMed ID: 3262194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
    Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
    Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of Langerhans cell histiocytosis: 39 years' experience at a single centre.
    Bernstrand C; Sandstedt B; Ahström L; Henter JI
    Acta Paediatr; 2005 Aug; 94(8):1073-84. PubMed ID: 16188852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans' cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases.
    Kilpatrick SE; Wenger DE; Gilchrist GS; Shives TC; Wollan PC; Unni KK
    Cancer; 1995 Dec; 76(12):2471-84. PubMed ID: 8625073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hungarian experience with Langerhans cell histiocytosis in childhood.
    Müller J; Garami M; Hauser P; Schuler D; Csóka M; Kovács G; Rényi I; Kovács G; Marosi A; Galántai I; Békési A; Kajtár P; Kiss CS; Nagy K; Bartyik K; Masáth P; Kriván G;
    Pediatr Hematol Oncol; 2006 Mar; 23(2):135-42. PubMed ID: 16651242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Langerhans cell histiocytosis in adult patients--a disease with many faces. Experience of a centre and an overview of the disease symptoms].
    Adam Z; Pour L; Krejcí M; Neubauer J; Vanícek J; Vasků V; Hájek R
    Vnitr Lek; 2008 Nov; 54(11):1063-80. PubMed ID: 19069680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine.
    Dhall G; Finlay JL; Dunkel IJ; Ettinger LJ; Kellie SJ; Allen JC; Egeler RM; Arceci RJ
    Pediatr Blood Cancer; 2008 Jan; 50(1):72-9. PubMed ID: 17455311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Langerhans cell histiocytosis of the cervical spine: a single Chinese institution experience with thirty cases.
    Jiang L; Liu ZJ; Liu XG; Zhong WQ; Ma QJ; Wei F; Dang GT; Yuan HS
    Spine (Phila Pa 1976); 2010 Jan; 35(1):E8-15. PubMed ID: 20042947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Langerhans cell histiocytosis of bone in children and adolescents.
    Ghanem I; Tolo VT; D'Ambra P; Malogalowkin MH
    J Pediatr Orthop; 2003; 23(1):124-30. PubMed ID: 12499958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerhans cell histiocytosis in Turkish children.
    Tokuç G; Boran P; Oktem S
    Turk J Pediatr; 2009; 51(4):344-9. PubMed ID: 19950841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healing rates of treated and untreated bone lesions in histiocytosis X.
    Womer RB; Raney RB; D'Angio GJ
    Pediatrics; 1985 Aug; 76(2):286-8. PubMed ID: 3875075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study.
    Titgemeyer C; Grois N; Minkov M; Flucher-Wolfram B; Gatterer-Menz I; Gadner H
    Med Pediatr Oncol; 2001 Aug; 37(2):108-14. PubMed ID: 11496348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Langerhans' cell histiocytosis of the temporal bone in children.
    Saliba I; Sidani K; El Fata F; Arcand P; Quintal MC; Abela A
    Int J Pediatr Otorhinolaryngol; 2008 Jun; 72(6):775-86. PubMed ID: 18355926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.